The Harvard Medical School Cancer Biology and Therapeutics Program (HMS-CBT) is a joint initiative of the Harvard Medical School Office of Global Education and the Qatar Biomedical Research Institute (QBRI). HMS-CBT is a 12-month blended-learning program (hms.harvard.edu/cbt) designed to provide participants with deep knowledge of the cancer biology that shapes modern preventive and therapeutic approaches.
Senior faculty from Harvard Medical School, Harvard School of Public Health and Harvard Business School and other leading international academic institutions
A blend of online and live teaching
24/7 access to learning content at a location convenient to you
Faculty available to participants throughout the program
The course structure will be comprised of:
Approximately 60 online lectures -- Lectures are one hour and, once posted online, will remain available for one year. Online lectures can be accessed via computers running either an Apple or Windows operating system, and will have associated practicums and/or homework assignments
Two to three interactive webinars per month (for review and problem solving) -- The webinars will include review sessions by faculty or journal club sessions during which a faculty member will review a journal article or a recent online lecture. They will also provide the opportunity for question and answer “office-hour” session
Three Workshops -- The workshops will be held over a three-to-five day period
Who Should Apply?
Candidates holding an MD, PhD, MBBS, DMD, DDS, PharmD, DNP, or equivalent degree are eligible to apply. Candidates with a Master's degree will be considered for admission on a case-by-case basis.
QBRI will offer a limited number of full and partial scholarships to qualified participants from the Gulf Cooperation Council (GCC) and Middle East North Africa (MENA). These Scholarships are awarded on the basis of merit and conditions stipulated by the sponsor.
Loic Yengo, Abdelilah Arredouani, Michel Marre, Ronan Roussel, Martine Vaxillaire, Mario Falchi, Abdelali Haoudi, Jean Tichet, The D.E.S.I.R Study Group, Beverley Balkau, Amélie Bonnefond, Philippe Froguel
A group of scientists led by Dr. Abdelilah Arredouani from the Diabetes Research Center at the Qatar Biomedical Research Institute (QBRI), a research institute of Hamad bin Khalifa University (HBKU)...